Biallelic pathogenic MUTYH mutations substantially increase colorectal cancer risk, but whether risks are also elevated for heterozygote MUTYH carriers or predispose towards additional cancer types remains unclear and controversial [39,40], and the association between MUTYH mutations and either PrCa onset or aggressiveness has not adequately been studied previously. Here, MUTYH is linked to cancer.